Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors.

Br J Cancer · 2004 · PMC2409797 · PMID 15597103

Europe PMC DOI

hedged sentence

0.0740

closest p · 1.5× alpha

0.0740

boldest claim

The sentences

showed a trendP =0.074so close (0.05 < p ≤ 0.1)

Patients with an MVD above the median (23 MPF) showed a trend towards a longer OS compared to those with an MVD below the median (12.9 vs 10.1 months; P =0.074).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.